Unfortunately some here refused to look at the facts, US sales in 2H was disappointing to say the least, don’t need a PhD in finance to see it. Pointed it out as an early warning signal not a stop sign, don’t want to see it being stagnant given the extra sales staff and some of them being on the ground for awhile already. RoW save the day really in the 2H, gave PNV the market consensus growth for FY22. I am still hopefully for 23 m in Q1 and 26m for Q2. More than anything I would like the BoD and CEO be more forthcoming in providing sales update. More information for the market the merrier IMO, part of the SP going south is market’s vote of no confidence. One only have to look at AVH SP in comparison to see the difference in the last 6 mths. IMP Avh don’t compare to PNV fundamentally but fact is their shareholders have done better than us.
Getting disillusioned, page-12
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.34 |
Change
-0.020(0.85%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.37 | $2.32 | $2.004M | 857.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2441 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.34 | 19571 | 5 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.33 |
Change
-0.020 ( 1.24 %) |
||||
| Open | High | Low | Volume | ||
| $2.34 | $2.37 | $2.32 | 261156 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PNV (ASX) Chart |